Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13633
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tantisiriwat W. | |
dc.contributor.author | Santiwattanakul S. | |
dc.date.accessioned | 2021-04-05T03:25:10Z | - |
dc.date.available | 2021-04-05T03:25:10Z | - |
dc.date.issued | 2015 | |
dc.identifier.issn | 1252208 | |
dc.identifier.other | 2-s2.0-84957716993 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13633 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957716993&partnerID=40&md5=60b202cacabbfe993878296c9877b11d | |
dc.description.abstract | Objective: To identify the epidemiology of candida isolations in HRH Princess Maha Chakri Sirindhorn Medical Center and the sensitivity of all candida species to fluconazole. Material and Method: Two hundred of Candida albicans and other Candida species from clinical specimens were collected from microbiological department between January 2010 and April 2012. All Candida were identified by standard methods and the sensitivity of fluconazole was tested by using fluconazole E test test. Results: There were 8 species of Candida in this study including: C. albicans (n = 94), C. tropicalis (n = 66), C. glabrata (n = 11), C. guilliermondii (n = 10), C. parapsilosis (n = 9), C. zeylanoides (n = 4), C. keyfr (C. pseudotropicalis) (n = 2), C. lusitaniae (n = 1), Candida species (n = 3). The percentage of non-albicans Candida spp. was slightly higher than C. albicans (53% vs. 47%). C. tropicalis was identified as the highest percentage of all non-albicans Candida spp. Fluconazole resistant strains were detected among C. albicans (35.71%), C. tropicalis (13.85%), C. guilliermondii (20.0%), and C. zeylanoides (50.0%). The common spp. with highest percentage of resistant strain was C. albicans. Conclusion: Fluconazole could be used as the first-line antifungal for candidiasis at HRH Princess Maha Chakri Sirindhorn Medical Center. Empirical treatment with amphotericin B and stepping down to fluconazole when sensitivity suggested might be the recommendation for severe cases in our setting. © 2015, Medical Association of Thailand. All rights reserved. | |
dc.subject | amphotericin B | |
dc.subject | fluconazole | |
dc.subject | amphotericin B | |
dc.subject | antifungal agent | |
dc.subject | fluconazole | |
dc.subject | antibiotic sensitivity | |
dc.subject | Article | |
dc.subject | Candida albicans | |
dc.subject | Candida glabrata | |
dc.subject | Candida parapsilosis | |
dc.subject | Candida tropicalis | |
dc.subject | Candida zeylanoides | |
dc.subject | candidemia | |
dc.subject | candidiasis | |
dc.subject | Clavispora lusitaniae | |
dc.subject | Kluyveromyces marxianus | |
dc.subject | Meyerozyma guilliermondii | |
dc.subject | minimum inhibitory concentration | |
dc.subject | nonhuman | |
dc.subject | prospective study | |
dc.subject | sensitivity analysis | |
dc.subject | Candida | |
dc.subject | candidiasis | |
dc.subject | human | |
dc.subject | isolation and purification | |
dc.subject | microbial sensitivity test | |
dc.subject | procedures | |
dc.subject | United States | |
dc.subject | university hospital | |
dc.subject | Academic Medical Centers | |
dc.subject | Amphotericin B | |
dc.subject | Antifungal Agents | |
dc.subject | Candida | |
dc.subject | Candida albicans | |
dc.subject | Candidiasis | |
dc.subject | Fluconazole | |
dc.subject | Humans | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Prospective Studies | |
dc.subject | United States | |
dc.title | Epidemiology of candida infections in HRH princess maha chakri sirindhorn medical center, srinakharinwirot university | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of the Medical Association of Thailand. Vol 98, (2015), p.S66-S70 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.